Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-022-00554-1
Publication URI: http://dx.doi.org/10.1038/s41541-022-00554-1
Type: Journal Article/Review
Parent Publication: npj Vaccines
Issue: 1